Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quintiles Restructuring To Move Drug Development Process Online

Executive Summary

Quintiles will convert all aspects of its drug development process, including clinical trial recruitment and physician payment, into web transactions by 2002, the firm indicated during a Jan. 24 conference call announcing its Internet partnership with Healtheon/WebMD.
Advertisement

Related Content

Quintiles Expects Expanded Services Contribution To CSO To Be 50% By 2005
Quintiles Expects Expanded Services Contribution To CSO To Be 50% By 2005
Covance Tissue Sample Stockpile Is Possible Asset For Genomics Research
Medco Founder Wygod Will Focus On Payor Relations At WebMD As Co-Ceo
CROs Counting On Biotech Stock Rise, Phase IV Trials To Drive New Business
Envoy
Quintiles Rx Market Monitor Provides Real-Time Rx Share Info On Internet
Healtheon Paying $5 Bil. For CareInsite, Symbolic Role As New Medco
Quintiles Adds Information Services To Contract Research & Sales Base
Quintiles Adds Information Services To Contract Research & Sales Base
Advertisement
UsernamePublicRestriction

Register

PS035533

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel